Connor, Clark & Lunn Investment Management (CC&L)
XERS icon

Connor, Clark & Lunn Investment Management (CC&L)’s Xeris Biopharma Holdings XERS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Sell
407,625
-651,067
-61% -$4.32M 0.01% 913
2025
Q4 		$8.31M Sell
1,058,692
-640,065
-38% -$5.04M 0.02% 510
2025
Q3 		$13.8M Buy
1,698,757
+470,798
+38% +$3.13M 0.04% 338
2025
Q2 		$5.73M Buy
1,227,959
+638,488
+108% +$2.93M 0.02% 536
2025
Q1 		$3.24M Buy
589,471
+418,139
+244% +$1.69M 0.01% 607
2024
Q4 		$581K Buy
171,332
+88,224
+106% +$284K ﹤0.01% 1105
2024
Q3 		$237K Buy
+83,108
New +$213K ﹤0.01% 1294
2022
Q2 		– Sell
-28,897
Closed -$74K – 1219
2022
Q1 		$74K Buy
+28,897
New +$70.6K ﹤0.01% 990

Other funds holding XERS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return